Fundraising Fox
Okomera
Founded 2020 · 24 employees on LinkedIn · 2 known investors
Find your way into Okomera
Sign up to see every warm intro you have to Okomera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Okomera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Okomera builds a platform combining miniaturized tumor-on-chip technology and AI imaging to analyze patient-derived biopsies and predict personalized drug response for cancer treatment. Its tools serve clinicians and drug developers, spanning drug development to clinical decision-making.
Founders & leadership
Okomera was founded in 2020 by Raphaël Tomasi.
RT
Raphaël TomasiFounder · OkomeraformerCo-founder and CTO of Okomera, where he leads development of an automated droplet microfluidics platform enabling 3D culture and testing of patient cancer cells for precision cancer medicine. He has over 10 years of experience in microfluidics research, with several journal publications and filed patents.
Investors · 2
In the news
Frequently asked questions
- What does Okomera do?
- Okomera builds a platform combining miniaturized tumor-on-chip technology and AI imaging to analyze patient-derived biopsies and predict personalized drug response for cancer treatment. Its tools serve clinicians and drug developers, spanning drug development to clinical decision-making.
- Who founded Okomera?
- Okomera was founded by Raphaël Tomasi in 2020.
- Who are Okomera's investors?
- Okomera's investors include Polytechnique Ventures, Resonance VC.